B. Bolinder

Development and validation of the Economic Assessment of Glycemic Control and Long-Term Effects of diabetes (EAGLE) model.

N. Freemantle, E. Mueller, S. Maxion-Bergemann, 2006, Diabetes technology & therapeutics.

Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United States

B. Bolinder, Gordon H. Sun, T. Bentley, 2014, American journal of clinical oncology.

Cost-effectiveness analysis of second-line tyrosine kinase inhibitor treatment for chronic myelogenous leukemia

B. Bolinder, E. Felber, Dinara Makenbaeva, 2016, Journal of medical economics.

QIM20-132: A Tool Preparing Patients with Stage III Non-Small Cell Lung Cancer for Shared Decision-Making: Validating Acceptability and Usability

B. Bolinder, A. Clary, C. Yong, 2020 .

The Effectiveness of Tyrosine Kinase Inhibitors and Molecular Monitoring Patterns in Newly Diagnosed Patients With Chronic Myeloid Leukemia in the Community Setting.

B. Bolinder, D. Patt, E. Jabbour, 2015, Clinical lymphoma, myeloma & leukemia.

Cost of hypoglycemia in patients with Type 2 diabetes in Sweden.

B. Bolinder, L. Jönsson, J. Lundkvist, 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002.

B. Bolinder, K. Fox, Sanjaya Kumar, 2006, Clinical therapeutics.

The economic and quality of life impact of hypoglycemia

B. Bolinder, C. Berne, L. Jönsson, 2005, The European Journal of Health Economics.

Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes.

Joseph C Cappelleri, J. Rosenstock, B. Bolinder, 2004, Diabetes care.

Availability of inhaled insulin promotes greater perceived acceptance of insulin therapy in patients with type 2 diabetes.

Nick Freemantle, Lawrence Blonde, Didier Duhot, 2005, Diabetes care.

Real-world trials to answer real-world questions

N. Freemantle, B. Bolinder, R. Gerber, 2012, PharmacoEconomics.

Does rapid transition to insulin therapy in subjects with newly diagnosed type 2 diabetes mellitus benefit glycaemic control and diabetes-related complications? A German population-based study.

H. Vinod, B. Bolinder, R. Gerber, 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Estimating Productivity Loss from Breast and Non–Small-Cell Lung Cancer among Working-Age Patients and Unpaid Caregivers: A Survey Study Using the Multiplier Method

B. Bolinder, K. Batt, K. Bognar, 2022, MDM policy & practice.